Clinical Trial Update: Safety and Immunogenicity of a 10 Valent Pneumococcal Conjugate Vaccine (SIILPCV10) in Healthy Adults, Toddlers, Infants [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial assessing safety and immunogenicity of a 10-valent pneumococcal conjugate vaccine (SIILPCV10) in healthy adults, toddlers, and infants; study co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Disease

Drugs mentioned

• SIILPCV10 (10-valent pneumococcal conjugate vaccine)

Snippet

Sponsor: PATH | Conditions: Pneumococcal Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-08-02